FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

AA Chines

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Procedures

Anatomy

Physiology

Bone Resorption

Devices

Placebos

Co-author Network

Publications

TOP 3
S L Silverman; C S Teglbjærg; Jonathan D Adachi; AA Chines; Ginger D Constantine; D Felsenberg; David L Kendler; A W C Kung; N Mairon
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study.
Nelson B Watts; AA Chines; Wojciech P Olszynski; C D McKeever; Michael R McClung; X Zhou; Andreas Grauer
Fracture risk remains reduced one year after discontinuation of risedronate.
Louis-Georges Ste-Marie; E Sod; T Johnson; AA Chines
Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of AA Chines (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: S L Silverman; C S Teglbjærg; Jonathan D Adachi; AA Chines; Ginger D Constantine; D Felsenberg; David L Kendler; A W C Kung; N Mairon
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2012;23(1):351-63.
2008: Nelson B Watts; AA Chines; Wojciech P Olszynski; C D McKeever; Michael R McClung; X Zhou; Andreas Grauer
Fracture risk remains reduced one year after discontinuation of risedronate.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008;19(3):365-72.
2004: Louis-Georges Ste-Marie; E Sod; T Johnson; AA Chines
Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis.
Calcified tissue international 2004;75(6):469-76.
2004: Steven T Harris; Nelson B Watts; Z Li; AA Chines; David A Hanley; Jacques P Brown
Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis.
Current medical research and opinion 2004;20(5):757-64.
2003: Ana Munoz; Ian P Barton; Rosemary A Hannon; AA Chines; P Garnero; P D Delmas
Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(6):1051-6.
2002: Erik Fink Eriksen; Flemming Melsen; E Sod; Ian P Barton; AA Chines
Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis.
Bone 2002;31(5):620-5.
2001: Steven T Harris; Erik Fink Eriksen; M Davidson; Mark P Ettinger; A H Moffett Jr; David J Baylink; C E Crusan; AA Chines
Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.
The Journal of clinical endocrinology and metabolism 2001;86(5):1890-7.
2001: Jacques P Brown; Wojciech P Olszynski; Anthony B Hodsman; WG Bensen; Alan Tenenhouse; Tassos Anastassiades; Louis-Georges Ste-Marie; David L Kendler; David A Hanley; Robert G Josse; J G Hanly; Brian C Lentle; A Jovaisas; George Ioannidis; Gregory F Stephenson; Ian P Barton; S Pack; AA Chines; R Dias; Jonathan D Adachi
Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroids.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2001;4(4):363-71.
2000: S Wallach; S Cohen; D M Reid; R A Hughes; David J Hosking; R F Laan; S M Doherty; M Maricic; C Rosen; Jacques Brown; Ian P Barton; AA Chines
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy.
Calcified tissue international 2000;67(4):277-85.
2000: Jacques P Brown; AA Chines; W R Myers; Rachelle A Eusebio; C Ritter-Hrncirik; C W Hayes
Improvement of pagetic bone lesions with risedronate treatment: a radiologic study.
Bone 2000;26(3):263-7.
2000: Ana Munoz; JP Devogelaer; Nicola F A Peel; AA Chines; D E Bax; NA Sacco-Gibson; C Nagant de Deuxchaisnes; R Graham G Russell
Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2000;11(4):331-7.
1999: S Cohen; R M Levy; M Keller; E Boling; R D Emkey; M Greenwald; THOMAS ZIZIC; S Wallach; K L Sewell; B P Lukert; D W Axelrod; AA Chines
Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Arthritis and rheumatism 1999;42(11):2309-18.
1998: Ethel S Siris; AA Chines; R D Altman; Jacques P Brown; CC Johnston; R Lang; Michael R McClung; L E Mallette; Paul D Miller; W G Ryan; Frederick R Singer; Joseph R Tucci; Rachelle A Eusebio; Pirow J Bekker
Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1998;13(6):1032-8.
1998: David J Hosking; Rachelle A Eusebio; AA Chines
Paget's disease of bone: reduction of disease activity with oral risedronate.
Bone 1998;22(1):51-5.
1997: Jonathan D Adachi; WG Bensen; Jacques Brown; David Hanley; Anthony B Hodsman; Robert G Josse; David L Kendler; Brian C Lentle; Wojciech P Olszynski; Louis-Georges Ste-Marie; Alan Tenenhouse; AA Chines
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
The New England journal of medicine 1997;337(6):382-7.